Blood Work Education
YOUR BLOOD WORK EXPLAINED
A complete guide to the 62 biomarkers in your comprehensive blood panel — what each domain measures, how markers connect, and how to interpret your results.
Medically reviewed by Missy Zammichieli, DNP, APRN, FNP-BC ยท Updated March 2, 2026
THE BOTTOM LINE
- • You got more than a standard panel. Most annual physicals check 8-14 markers. Yours checks 62 across 10 systems — heart, metabolism, hormones, thyroid, liver, kidneys, blood cells, vitamins, and inflammation. That gives you and your provider a much fuller picture.
- • Patterns matter more than any single number. A “normal” fasting glucose means less if your insulin and triglycerides tell a different story. This panel is designed to catch those connections.
- • Trends over time beat any single draw. One result is a snapshot. Two or three over a year show you the direction things are heading — and that is where the real value is.
- • Your provider reads these results in context. Reference ranges are starting points, not verdicts. Age, activity level, medications, and your goals all factor in.
WHY COMPREHENSIVE BLOOD WORK MATTERS
A standard annual physical checks 8-14 markers — enough to confirm nothing is acutely wrong, but not much more. It is designed to screen for disease, not to show how each system is actually performing.
A 62-biomarker panel asks a different question: instead of “is anything broken?”, it asks “how is everything running?” That matters because conditions like heart disease, metabolic syndrome, and hormonal decline develop gradually over years before they become diagnosable. A broader panel catches those shifts early, when you have the most options.
This is not about finding problems where none exist. It is about having enough data to make informed decisions. A standard panel might show your fasting glucose at 99 mg/dL — technically normal — and move on. This panel shows that glucose alongside your insulin, HbA1c, and triglycerides, giving a much more complete picture of your metabolic health.
This guide walks through each domain, explains how to read your results, and gives you the framework for understanding what your blood work is telling you.
HOW TO READ YOUR REPORT: REFERENCE RANGES VS. TARGETS
Every result on your report comes with a reference range — the “normal range” printed next to your value. Here is what that actually means.
Reference ranges come from population statistics. Labs test a large group of apparently healthy people and define the middle 95% as “normal.” Think of it like height — if you measured 1,000 adults, the middle 95% would fall in a certain range. That does not mean being slightly outside the range is a problem. And being inside the range does not guarantee everything is optimal. It just means your value is common.
Medical society guidelines set tighter targets based on outcomes. Groups like the American Heart Association (AHA) and the American Diabetes Association (ADA) publish targets tied to actual health outcomes — not just what is common, but what is associated with lower risk. For example, a lab reference range for LDL cholesterol might go up to 130 mg/dL, but AHA guidelines recommend below 70 mg/dL for people at elevated heart risk. Those are different questions: “Is this value common?” versus “Is this value associated with lower risk?”
Your provider interprets both in the context of your history, risk factors, and goals.
THE 10 DOMAINS OF YOUR PANEL
Your 62 biomarkers are organized into 10 domains. Here is what each one covers and why it matters to you.
1. Cardiovascular and Lipids
Lp(a), Total Cholesterol, HDL, Triglycerides, LDL, Cholesterol/HDL Ratio, Non-HDL Cholesterol, ApoB
This is your heart health snapshot. Beyond standard cholesterol, it includes ApoB — which many cardiologists now consider the best single measure of heart disease risk — and Lp(a), a genetic risk factor the National Lipid Association recommends every adult check at least once.
2. Metabolic and Blood Sugar
Fasting Insulin, Fasting Glucose, BUN/Creatinine Ratio, HbA1c
This tells you how your body handles energy. Most standard panels only check glucose, but adding fasting insulin shows how hard your body is working to keep blood sugar stable — an early warning sign that can show up years before glucose or HbA1c start to shift.
3. Hormones and Endocrine
SHBG, Free Testosterone, Bioavailable Testosterone, Total Testosterone, DHEA-S, FSH, LH, Estradiol, PSA
These markers affect your energy, body composition, mood, and recovery. This panel measures total testosterone plus free and bioavailable testosterone because conditions like obesity can lower total testosterone even when your usable testosterone is fine. You need all three to get the real picture.
4. Thyroid Function
TSH, Free T4, Free T3, TPO Antibodies
Your thyroid controls your metabolism, energy level, and body temperature. TSH is the primary screening marker, but adding Free T4, Free T3, and TPO antibodies shows whether your thyroid is converting hormones properly and whether your immune system is attacking the gland.
5. Liver Function
Albumin, Total Protein, Globulin, A/G Ratio, Total Bilirubin, Alkaline Phosphatase (ALP), AST, ALT
Your liver processes everything — nutrients, medications, alcohol, toxins. These markers show how well it is keeping up. One important note for active people: AST is found in muscle too, so a hard training week can elevate it. ALT is more liver-specific and helps your provider tell the difference.
6. Kidney Function
BUN, Creatinine, eGFR, Sodium, Potassium, Chloride, CO2, Calcium
Your kidneys filter waste, balance electrolytes, and regulate fluids. eGFR is the standard measure of how well they are filtering. The electrolyte panel (sodium, potassium, chloride, CO2) reflects your hydration and acid-base balance.
7. Blood Cells and Counts
Complete Blood Count with Differential (15 markers including WBC, RBC, Hemoglobin, Hematocrit, MCV, MCH, MCHC, RDW, Platelets, Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils, Immature Granulocytes)
The CBC covers three systems: red blood cells (oxygen delivery), white blood cells (immune defense), and platelets (clotting). The red cell indices can help identify whether you are low on iron, B12, or something else. The white cell breakdown shows which parts of your immune system are active.
8. Vitamins and Nutrients
Vitamin D (25-hydroxyvitamin D), Vitamin B12
Two nutrients with widespread effects. Vitamin D impacts bone health, immune function, and mood. B12 is essential for energy, nerve function, and red blood cell production — and deficiency is more common than most people realize, especially in certain diets.
9. Inflammation Markers
High-Sensitivity C-Reactive Protein (hs-CRP)
This measures low-grade inflammation throughout your body. According to AHA guidelines, levels below 1 mg/L, 1-3 mg/L, and above 3 mg/L correspond to lower, moderate, and higher heart risk. Because CRP rises with any inflammation — a recent cold, a hard workout, an injury — your provider will consider context when reading this number.
10. Patterns: How Markers Connect Across Domains
The tenth section looks at how markers from different domains interact. This is where a comprehensive panel pays off — patterns that no single number can reveal on its own.
HOW MARKERS CONNECT: WHY PATTERNS MATTER MORE THAN INDIVIDUAL NUMBERS
Your body is an integrated system. The most useful insights often come from relationships between markers, not from any single value.
Metabolic + Cardiovascular. High fasting insulin and triglycerides combined with low HDL is a well-documented pattern linked to insulin resistance and increased heart risk — even when fasting glucose and LDL look normal. Looking at these markers separately would miss the story they tell together.
Thyroid + Hormones. Thyroid hormones affect SHBG production, which changes the balance between total and free testosterone. Low SHBG on a hormone panel might point to a thyroid issue as the underlying cause — a connection that is invisible if you test these separately.
Inflammation + Metabolic Health. Elevated CRP alongside insulin resistance and high triglycerides suggests a metabolic inflammatory state with compounding heart risk. That tells a different story than elevated CRP alone, which could just mean you had a cold last week.
Kidney + Electrolytes. A mildly elevated creatinine might mean kidney stress — or it might just mean you were dehydrated. The broader panel with electrolytes and hydration markers helps your provider tell the difference.
Liver + Activity Level. Elevated AST in someone who trains hard may reflect muscle breakdown, not liver damage. When ALT (liver-specific) stays normal while AST is high, the interpretation shifts entirely.
The value of comprehensive testing is not in collecting more numbers. It is in enabling your provider to read those numbers as a connected system.
WHAT CAN AFFECT YOUR RESULTS
Blood work is a snapshot from the moment of your draw. Several factors can shift your numbers. Knowing them helps you prepare and interpret your results.
Fasting
Most panels require a 10-12 hour fast to standardize glucose, insulin, and triglyceride readings. Do not fast longer than 16 hours — that can distort results too. Water is fine and encouraged.
Hydration
Dehydration concentrates your blood and can artificially raise hemoglobin, creatinine, BUN, and electrolytes. Drink water (not sugary drinks) before your draw.
Exercise Timing
Hard training within 24-48 hours of your draw can significantly alter results. A study in the British Journal of Sports Medicine found that intense weightlifting can elevate AST and ALT for up to seven days. Intense exercise also temporarily lowers testosterone and raises cortisol. Avoid hard training for at least 48 hours before your draw.
Sleep
Poor sleep changes hormone and metabolic markers. Research shows that sleep restriction lowers testosterone, raises cortisol, and can reduce insulin sensitivity by roughly 40%. Aim for a normal night of sleep before your draw.
Supplements and Medications
Biotin (common in hair, skin, and nail supplements) can cause falsely abnormal thyroid results. The FDA recommends stopping biotin at least 72 hours before blood work. Medications like statins, metformin, and hormone therapy will obviously affect the markers they target — your provider accounts for this.
Stress
High stress elevates cortisol and can affect glucose, insulin, and inflammation markers. You cannot always control this, but knowing it helps with interpretation.
Time of Day
Testosterone peaks in the early morning and drops throughout the day, which is why the Endocrine Society recommends testing between 7:00 and 10:00 AM. Most panels are designed for a morning fasting draw to standardize these variables.
HOW OFTEN TO RETEST
Retesting frequency depends on your results, risk factors, and your provider’s judgment. Some general frameworks from medical society guidelines:
- Metabolic markers: Annually if you show signs of prediabetes. Every three years if results are normal, starting at age 35.
- Lipid panel: Every 4-6 years if you are low risk. More often if results are abnormal or you are on medication.
- Thyroid: Based on clinical context — more often if you have risk factors, family history, or prior abnormal results.
- Hormones: Low testosterone should be confirmed with a repeat morning draw before starting any treatment.
- Kidney function: At least annually if there is an established issue.
The big picture: One blood draw is one data point. Two or three over a year show you the trend — and trends are far more informative than any single result. Talk to your provider about the right retesting schedule for your situation.
References
- 1. MedlinePlus. Basic Metabolic Panel (BMP). U.S. National Library of Medicine. Available at: https://medlineplus.gov/lab-tests/basic-metabolic-panel-bmp/
- 2. Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279-2290.
- 3. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. Eur Heart J. 2017;38(32):2459-2472.
- 4. Horowitz GL. Reference intervals: practical aspects. eJIFCC. 2008;19(2):95-105.
- 5. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082-e1143.
- 6. Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiol. 2019;4(12):1287-1295.
- 7. Wilson DP, Jacobson TA, Jones PH, et al. Use of lipoprotein(a) in clinical practice: a biomarker whose time has come. A scientific statement from the National Lipid Association. J Clin Lipidol. 2022;16(5):e71-e95. (Updated 2024.)
- 8. Kronenberg F, Mora S, Stroes ESG, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925-3946.
- 9. American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes — 2025. Diabetes Care. 2025;48(Suppl 1):S27-S49.
- 10. Kraft JR. Detection of diabetes mellitus in situ (occult diabetes). Lab Med. 1975;6(2):10-22.
- 11. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.
- 12. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028.
- 13. Pettersson J, Hindorf U, Persson P, et al. Muscular exercise can cause highly pathological liver function tests in healthy men. Br J Clin Pharmacol. 2008;65(2):253-259.
- 14. Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017;112(1):18-35.
- 15. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314.
- 16. George-Gay B, Parker K. Understanding the complete blood count with differential. J Perianesth Nurs. 2003;18(2):96-117.
- 17. Maner BS, Moosavi L. Mean Corpuscular Volume. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2024.
- 18. Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024;109(8):1907-1947.
- 19. Stabler SP. Vitamin B12 deficiency. N Engl J Med. 2013;368(2):149-160.
- 20. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195-2207.
- 21. Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415-3537.
- 22. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607.
- 23. McLaughlin T, Reaven G, Abbasi F, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96(3):399-404.
- 24. Dumoulin SC, Perret BP, Bennet AP, Caron PJ. Opposite effects of thyroid hormones on binding proteins for steroid hormones (sex hormone-binding globulin and corticosteroid-binding globulin) in humans. Acta Endocrinol (Copenh). 1995;132(5):594-598.
- 25. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation. 2003;107(3):391-397.
- 26. Fernandez C, Siest G, Galli J, Batt AM, Herber R. Fasting conditions: influence of water intake on clinical chemistry analytes. Clin Chem Lab Med. 2017;55(12):1893-1900.
- 27. Kackov S, Simundic AM, Gils C. Volume depletion and hemoconcentration: pre-analytical effects on clinical chemistry results. Biochem Med (Zagreb). 2020;30(1):010704.
- 28. Brancaccio P, Maffulli N, Limongelli FM. Creatine kinase monitoring in sport medicine. Br Med Bull. 2007;81-82(1):209-230.
- 29. Hackney AC. Stress and the neuroendocrine system: the role of exercise as a stressor and modifier of stress. Expert Rev Endocrinol Metab. 2006;1(6):783-792.
- 30. Wittert G, Grossmann M. Sleep, testosterone and cortisol balance, and ageing men. Rev Endocr Metab Disord. 2022;23(6):1129-1139.
- 31. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435-1439.
- 32. U.S. Food and Drug Administration. The FDA Warns that Biotin May Interfere with Lab Tests: FDA Safety Communication. Updated 2019. Available at: https://www.fda.gov/medical-devices/safety-communications/update-fda-warns-biotin-may-interfere-lab-tests-fda-safety-communication
- 33. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5(7):374-381.
- 34. Boelaert K, Franklyn JA. Thyroid hormone in health and disease. J Endocrinol. 2005;187(1):1-15.